Abstract
Oral tolerance induction with peptide B27PD had an ameliorating effect in uveitis patients, which was also observed in the five-year follow-up period. Repeated treatments with peptide B27PD were also effective. Side effects did not occur in this patient group, not even in patients receiving peptide for up to 42 weeks.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adjuvants, Immunologic / therapeutic use*
-
Amino Acid Sequence
-
Follow-Up Studies
-
HLA-B27 Antigen / immunology*
-
Humans
-
Immune Tolerance*
-
Immunity, Mucosal*
-
Peptide Fragments / immunology*
-
Peptide Fragments / therapeutic use
-
Time Factors
-
Uveitis / immunology*
-
Uveitis / therapy
-
Visual Acuity / immunology
Substances
-
Adjuvants, Immunologic
-
HLA-B27 Antigen
-
Peptide Fragments